Gantz, Timothy, Early Greek Myth: A Guide to Literary and Artistic Sources, Johns Hopkins University Press, 1996, Two volumes: ISBN 978-0-8018-5360-9 (Vol. 1), ISBN 978-0-8018-5362-3 (Vol. 2). Griffin, H. F., "Unrequited Love: Polyphemus and Galatea in Ovids Metamorphoses", in Greece & Rome, Vol. 30, No. 2 (Oct., 1983), pp. 190–197. JSTOR 642570. Grimal, Pierre, The Dictionary of Classical Mythology, Wiley-Blackwell, 1996. ISBN 978-0-631-20102-1. Hansen, William, Handbook of Classical Mythology, ABC-CLIO, 2004. ISBN 978-1576072264. Hard, Robin, The Routledge Handbook of Greek Mythology: Based on H.J. Roses "Handbook of Greek Mythology", Psychology Press, 2004, ISBN 9780415186360. Google Books. Heubeck, Alfred, J. B. Hainsworth, Stephanie West, A Commentary on Homers Odyssey: Volume I: Introduction and Books I–VIII, Oxford University Press, 1990. ISBN 0-19-814747-3. Heubeck, Alfred, Arie Hoekstra, A Commentary on Homers Odyssey: Volume II: Books IX–XVI, Oxford University Press, 1990. ISBN 0-19-872144-7. Hesiod, Theogony, in The Homeric Hymns and Homerica with an English Translation by Hugh G. Evelyn-White, Cambridge, Massachusetts., Harvard University Press; London, William Heinemann Ltd. 1914. Online version at the Perseus Digital Library. Homer, The Odyssey with an English Translation by A.T. Murray, PH.D. in two volumes. Cambridge, Massachusetts., Harvard University Press; London, William Heinemann, Ltd. 1919. Online version at the Perseus Digital Library. Hyginus, Gaius Julius, Fabulae in Apollodorus Library and Hyginus Fabulae: Two Handbooks of Greek Mythology, Translated, with Introductions by R. Scott Smith and Stephen M. Trzaskoma, Hackett Publishing Company,  2007. ISBN 978-0-87220-821-6. Leroi, Armand Marie, Mutants: On Genetic Variety and the Human Body, Penguin, 2003. ISBN 0-670-03110-0.
Lusutrombopag, sold under the brand name Mulpleta among others, is a medication that has been developed for certain conditions that lead to thrombocytopenia (abnormally low platelet counts) such as thrombocytopenia associated with chronic liver disease in patients prior to elective invasive procedures. It is being manufactured and marketed in Japan by Shionogi. It was approved by the U.S. Food and Drug Administration (FDA) in July 2018, and NICE in January 2020.It was approved for medical use in the European Union in February 2019. References
External links
"Lusutrombopag". Drug Information Portal. U.S. National Library of Medicine.